Inhibition of phagocytosis reduced the classical activation of BV2 microglia induced by amyloidogenic fragments of beta-amyloid and prion proteins

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 11, 2013, Pages 973-978

  Shi, Fushan ^a,b   Yang, Lifeng ^a   Wang, Jihong ^a   Kouadir, Mohammed ^a   Yang, Yang ^a   Fu, Yongyao ^a   Zhou, Xiangmei ^a   Yin, Xiaomin ^a   Zhao, Deming ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Microglial activation; Prion disease

Indexed keywords

AMYLOID BETA PROTEIN; PRIMER DNA;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MICROGLIA; MICROGLIAL ACTIVATION; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRION; PRION DISEASE;

ALZHEIMER'S DISEASE; MICROGLIAL ACTIVATION; PRION DISEASE;

AMYLOID BETA-PEPTIDES; ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICROGLIA; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIONS;

EID: 84888314356     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt101     Document Type: Article

References (25)

1. Ross CA and Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004, 10: 10-17.
2. Block ML, Zecca L and Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8: 57-69. (Pubitemid 46011999)
3. Yankner BA and Lu T. Amyloid b-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 2009, 284: 4755-4759.
4. Aguzzi A and Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006, 4: 765-775. (Pubitemid 44420127)
5. Floden AM, Li S and Combs CK. b-Amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor a and NMDA receptors. J Neurosci 2005, 25: 2566-2575. (Pubitemid 40365168)
6. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T and Fitzgerald KA, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-b. Nat Immunol 2008, 9: 857-865.
7. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O and Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993, 6420: 543-546. (Pubitemid 23113029)
8. Selvaggini C, Degioia L, Cantu L, Ghibaudi E, Diomede L, Passerini F and Forloni G, et al. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Bioph Res Co 1993, 194: 1380-1386. (Pubitemid 23255035)
9. Nimmerjahn A, Kirchhoff F and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308: 1314-1318. (Pubitemid 40746128)
10. Soulet D and Rivest S. Bone-marrow-derived microglia: myth or reality? Curr Opin Pharmacol 2008, 8: 508-518.
11. Garden GA and Möller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 2006, 1: 127-137. (Pubitemid 44257488)
12. Ransohoff RM and Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009, 27: 119-145.
13. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4: 399-418.
14. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L and Eagle AR, et al. Macrophage-specific PPAR controls alternative activation and improves insulin resistance. Nature 2007, 447: 1116-1120. (Pubitemid 47014427)
15. Brodie C, Goldreich N, Haiman T and Kazimirsky G. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J Neuroimmunol 1998, 81: 20-30. (Pubitemid 28248180)
16. Kitamura Y, Taniguchi T, Kimura H, Nomura Y and Gebicke-Haerter P. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J Neuroimmunol 2000, 106: 95-104. (Pubitemid 30256082)
17. van Rossum D, Hilbert S, Straßenburg S, Hanisch U and Brück W. Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 2007, 56: 271-283.
18. Kouadir M, Yang L, Tu J, Yin X, Zhou X and Zhao D. Comparison of mRNA expression patterns of class B scavenger receptors in BV2 microglia upon exposure to amyloidogenic fragments of beta-Amyloid and prion proteins. DNA Cell Biol 2011, 30: 893-897.
19. Garção P, Oliveira CR and Agostinho P. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration. J Neurosci Res 2006, 84: 182-193. (Pubitemid 44023073)
20. Levine H. Thioflavine T interaction with synthetic Alzheimer's disease - amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 1993, 2: 404-410.
21. Wong ML and Medrano JF. Real-time PCR for mRNA quantitation. BioTechniques 2005, 39: 75.
22. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM and Cooper NR, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21: 383-421. (Pubitemid 30349107)
23. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR and Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004, 17: 942-964. (Pubitemid 39372525)
24. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE and Vitek MP. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflamm 2006, 3: 27.
25. Rogers J and Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid b-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 2001, 39: 333-340. (Pubitemid 32907397)